A randomized double-blind placebo-controlled phase I/II clinical trial of a human papillomavirus therapeutic vaccine, PepCan, for reducing head and neck squamous cell carcinoma recurrence
Oncotarget · 05.06.2026 · 17 (1) · 291-305
DOI: 10.18632/oncotarget.28892 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Oncotarget, erschienen am 05.06.2026. Verfasst von Emily Bivens und 21 weiteren Autor:innen. Hauptthemen laut MEDLINE: Head and Neck Neoplasms, Neoplasm Recurrence, Local, Papillomavirus Vaccines, Carcinoma, Squamous Cell. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Förderung
- NCI NIH HHS
- NCATS NIH HHS
Zitieren
APA
Bivens, E., Atiq, O., Evans, T., Bimali, M., Brown, G., Crane, J., Darwish, N., Faulkner, J. L., Govindarajan, R., Johnson, A., Kurilung, A., Lazarenko, O., Lu, Y. W., Marsh, K., Moreno, M., Nookaew, I., Robeson, M., Sunde, J., Ussery, D., …, & Nakagawa, M. (2026). A randomized double-blind placebo-controlled phase I/II clinical trial of a human papillomavirus therapeutic vaccine, PepCan, for reducing head and neck squamous cell carcinoma recurrence. Oncotarget, 17(1), 291-305. https://doi.org/10.18632/oncotarget.28892
Vancouver
Bivens E, Atiq O, Evans T, Bimali M, Brown G, Crane J, et al. A randomized double-blind placebo-controlled phase I/II clinical trial of a human papillomavirus therapeutic vaccine, PepCan, for reducing head and neck squamous cell carcinoma recurrence. Oncotarget. 2026;17(1):291-305. doi:10.18632/oncotarget.28892
BibTeX
@article{Bivens2026,
author = {Bivens, Emily and Atiq, Omar and Evans, Teresa and Bimali, Milan and Brown, Ginger and Crane, Jasmine and Darwish, Nadia and Faulkner, Jennifer L and Govindarajan, Rangaswamy and Johnson, Aaron and Kurilung, Alongkorn and Lazarenko, Oxana and Lu, Yong-Chen William and Marsh, Keanna and Moreno, Mauricio and Nookaew, Intawat and Robeson, Michael and Sunde, Jumin and Ussery, David and Vural, Emre and Wilman, Mindy and Nakagawa, Mayumi},
title = {A randomized double-blind placebo-controlled phase I/II clinical trial of a human papillomavirus therapeutic vaccine, PepCan, for reducing head and neck squamous cell carcinoma recurrence},
journal = {Oncotarget},
year = {2026},
volume = {17},
number = {1},
pages = {291--305},
doi = {10.18632/oncotarget.28892}
}
EUVIMED